Quantifying infection risks in incompatible living donor kidney transplant recipients
Open Access
- 19 September 2020
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (4) , 1564-1575
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK113719, K01DK101677, K23DK115908, K24AI144954, RO1DK098431)
This publication has 25 references indexed in Scilit:
- Urinary Tract Infections in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- BK Polyomavirus in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous ImmunoglobulinClinical Journal of the American Society of Nephrology, 2011
- Desensitization in HLA-Incompatible Kidney Recipients and SurvivalNew England Journal of Medicine, 2011
- Doubly Robust Estimation of Causal EffectsAmerican Journal of Epidemiology, 2011
- Evaluating Evidence and Grading Recommendations: The SIS/IDSA Guidelines for the Treatment of Complicated Intra-Abdominal InfectionsSurgical Infections, 2010
- Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney‐Transplant PatientsAmerican Journal of Transplantation, 2009
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal TransplantationNew England Journal of Medicine, 2008
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008